Riboxin-Darnitsa
Release form:
Release form:
Complex treatment of coronary heart disease (condition after myocardial infarction, angina), arrhythmias, cardiac glycoside overdose; treatment of cardiomyopathies of different aetiology, myocardiodystrophies (associated with heavy physical activity, of infectious and endocrine aetiology), myocarditis; liver diseases (hepatitis, hepatic cirrhosis, fatty liver disease); porphyria cutanea tarda.